Literature DB >> 11810263

Characterisation of the allelic variation in the rpoS gene in thirteen K12 and six other non-pathogenic Escherichia coli strains.

T Atlung1, H V Nielsen, F G Hansen.   

Abstract

The nucleotide sequence of rpoS, the gene for the stress sigma factor, was determined in 13 different K12 strains of Escherichia coli. The results indicate that the original K12 isolate carried an amber mutation at codon 33, which in 50% of the derivatives is mutated by a single base substitution to a coding triplet, in most cases to CAG encoding glutamine. The six non-K12 strains examined here had GAG, encoding glutamate, in position 33. The two most divergent strains had three and seven neutral substitutions in rpoS and carried insertions of 2100 and 2900 bp, respectively, just downstream of the gene. The genetic variations in rpoS were compared with the variation in RpoS-related phenotypes, by measuring catalase (KatE) activity, glycogen accumulation and acid phosphatase levels, and a katEp-gfp fusion was used to visualise katE gene transcription. The RpoS phenotypes of the six rpoS(33E) strains varied significantly more than that of the K12 rpoS(33Q) strains, especially with respect to acid phosphatase levels. This was due to the absence of the gene for the transcriptional activator AppY from four of the rpoS(33E) strains, while all the K12 derivatives carried this gene. When cloned into a LacI-controlled vector and compared in a rpoS::Tn 10 background, the RpoS(33Q) and RpoS(33E) variants showed the same activity.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11810263     DOI: 10.1007/s00438-001-0610-0

Source DB:  PubMed          Journal:  Mol Genet Genomics        ISSN: 1617-4623            Impact factor:   3.291


  28 in total

1.  Effect of different concentrations of H-NS protein on chromosome replication and the cell cycle in Escherichia coli.

Authors:  T Atlung; F G Hansen
Journal:  J Bacteriol       Date:  2002-04       Impact factor: 3.490

2.  In vitro properties of RpoS (sigma(S)) mutants of Escherichia coli with postulated N-terminal subregion 1.1 or C-terminal region 4 deleted.

Authors:  J Gowrishankar; Kaneyoshi Yamamoto; P R Subbarayan; Akira Ishihama
Journal:  J Bacteriol       Date:  2003-04       Impact factor: 3.490

3.  Why are suppressors of amber mutations so frequent among Escherichia coli K12 strains?. A plausible explanation for a long-lasting puzzle.

Authors:  Dominique Belin
Journal:  Genetics       Date:  2003-10       Impact factor: 4.562

4.  FNR-mediated oxygen-responsive regulation of the nrdDG operon of Escherichia coli.

Authors:  T Boston; T Atlung
Journal:  J Bacteriol       Date:  2003-09       Impact factor: 3.490

5.  General stress response regulator RpoS in adaptive mutation and amplification in Escherichia coli.

Authors:  Mary-Jane Lombardo; Ildiko Aponyi; Susan M Rosenberg
Journal:  Genetics       Date:  2004-02       Impact factor: 4.562

6.  Polyamines are critical for the induction of the glutamate decarboxylase-dependent acid resistance system in Escherichia coli.

Authors:  Manas K Chattopadhyay; Herbert Tabor
Journal:  J Biol Chem       Date:  2013-10-04       Impact factor: 5.157

7.  Role of RpoS in the virulence of Citrobacter rodentium.

Authors:  Tao Dong; Brian K Coombes; Herb E Schellhorn
Journal:  Infect Immun       Date:  2008-11-03       Impact factor: 3.441

8.  Polymorphism and selection of rpoS in pathogenic Escherichia coli.

Authors:  Tao Dong; Sarah M Chiang; Charlie Joyce; Rosemary Yu; Herb E Schellhorn
Journal:  BMC Microbiol       Date:  2009-06-03       Impact factor: 3.605

9.  A stop codon-dependent internal secondary translation initiation region in Escherichia coli rpoS.

Authors:  Pochi Ramalingam Subbarayan; Malancha Sarkar
Journal:  RNA       Date:  2004-09       Impact factor: 4.942

10.  E Unibus Plurum: genomic analysis of an experimentally evolved polymorphism in Escherichia coli.

Authors:  Margie A Kinnersley; William E Holben; Frank Rosenzweig
Journal:  PLoS Genet       Date:  2009-11-06       Impact factor: 5.917

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.